Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Kick off an IRA with zero-commission index funds, focusing on cost-effective options and straightforward fund selection.
17,753 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
A rising governance proposal centers on a 5% government stake in OpenAI, aiming to align AI safety with policy goals ...
Palantir’s stock bounces back in early July after a rough June, with analysts pointing to AI-led growth and renewed d...
The GENIUS Act's one-year rulemaking deadline lands on July 18, placing stablecoin issuers under intense regulatory s...
President Trump’s Mount Rushmore appearance on Independence Day stirred political headlines and market caution. Early...
MicroStrategy is monetizing BTC to back dividends and bolster liquidity, draining a portion of its planned sale capac...
Tesla's latest moves in robotaxi expansion and a tease of a big announcement sparked a rally. Learn what drove the ju...
A fabless-focused ETF has surged roughly 58% this year as AI-driven design gains power, all while avoiding the world'...
Intel’s stock whipsawed after a dramatic breakout, triggering a deeper look at whether the move can sustain amid AI d...
Tesla’s latest delivery figures surprised many investors, fueling a potential rally. As tesla stock deliveries come i...
A new global liveability ranking places a major city at the bottom in 2026, triggering concerns about investment, hou...
Bitcoin sits near $63,000 as a familiar 91-day cycle returns to the spotlight. Traders say the bitcoin price predicti...